Strategy Asset Managers LLC Abiomed Inc Transaction History

Strategy Asset Managers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$175.89 - $279.23 $272,805 - $433,085	-1,551 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $1.43 Million - $1.62 Million	-5,697 Reduced 78.6%	1,551 $404,000
Q1 2019 May 08, 2019	BUY	$276.39 - $362.25 $1.06 Million - $1.39 Million	3,828 Added 111.93%	7,248 $2.07 Million
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $869,942 - $1.37 Million	-3,095 Reduced 47.51%	3,420 $1.11 Million
Q3 2018 Nov 01, 2018	BUY	$354.53 - $449.75 $2.31 Million - $2.93 Million	6,515 New	6,515 $0

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Strategy Asset Managers LLC, based on Form 13F filings with the SEC.

Stay updated on Strategy Asset Managers LLC with notifications on news.